TMJ Clinical Trials
Links shared publicly online about this topic
medcitynews.com — “Athersys (NASDAQ:ATHX), which is developing stem cell treatments, will work with University Hospitals Cleveland on a phase 2 clinical trial for ischemic stroke.” View full resource at medcitynews.com
Most Recently Shared on February 23, 2012 at 3:40 pm By:
medicalnewstoday.com — “Researchers are developing a new vaccine for hayfever which could be more effective, less invasive for patients and less expensive than vaccines already available to patients within the NHS.” View full resource at medicalnewstoday.com
Most Recently Shared on September 12, 2012 at 8:05 am By:
sciencedaily.com — “Medical researchers report promising results of the Phase I clinical trial of the generic drug BCG (bacillus Calmette-Guerin) to treat advanced type I diabetes.” View full resource at sciencedaily.com
Most Recently Shared on August 17, 2011 at 8:21 pm By:
Most Recently Shared on November 18, 2010 at 4:39 pm By:
Most Recently Shared on April 19, 2012 at 4:58 am By:
Most Recently Shared on August 20, 2012 at 3:00 pm By:
Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug, Hematide/peginesatide, Following Meeting with FDA
drugs.com — “Hematide (peginesatide) is a new drug in development for the treatment of anemia in chronic renal failure. Hematide information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on December 1, 2010 at 11:06 pm By:
medicalnewstoday.com — “A drug candidate that is nearing clinical trials against a Latin American parasite is showing additional promise as a cure for hookworm, one of the most widespread and insidious parasites afflicti” View full resource at medicalnewstoday.com
Most Recently Shared on July 5, 2012 at 8:05 am By:
Artificial Pancreas Android Phone at UVA RIGHT NOW!! - TuDiabetes - a community of people touched by diabetes
tudiabetes.org — “WOW, just got off the phone with clinical nurse manager at UVA's artificial pancreas division. they are doing trial in adolescents, a 10 hour study to see if t…” View full resource at tudiabetes.org
Most Recently Shared on May 5, 2012 at 5:37 am By:
nytimes.com — “Clinical trials indicate that BG-12, developed by Biogen Idec, may be safer and more effective than existing treatments for patients in the early stages of the disease.” View full resource at nytimes.com
Most Recently Shared on September 20, 2012 at 6:02 pm By:
In Sinusitis, Antibiotics Are as Effective as Placebos, Study Finds | Your Unified Airway: keeping it healthy | Scoop.it
scoop.it — “A new clinical trial found that a placebo worked just as well as the antibiotic amoxicillin in treating the runny nose, sneezing, cough, headache and other symptoms of sinusitis.” View full resource at scoop.it
Most Recently Shared on February 26, 2012 at 2:15 pm By:
nutraingredients-usa.com — “Consuming polyphenol-rich dark chocolate or cocoa products may reduce total and LD cholesterol levels, but has no effect on HDL levels, according to a meta-analysis of 10 clinical trials.” View full resource at nutraingredients-usa.com
Most Recently Shared on August 23, 2011 at 4:34 pm By:
news-medical.net — “Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.” View full resource at news-medical.net
Most Recently Shared on May 17, 2012 at 2:05 pm By:
smartbrief.com — “The FDA issued new safety warning labels for Eli Lilly and Co.'s attention-deficit/hyperactivity disorder treatment Strattera, or atomoxetine, for people with serious heart conditions. The agency reviewed clinical trials and found that 5% to 10% of adults and children experienced increases in blood…” View full resource at smartbrief.com
Most Recently Shared on July 18, 2012 at 7:22 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
UH offers a full range of primary and specialty health services for adults and children.
The latest immune system and vaccines news published daily. Articles from research centers, universities and prestigious journals.
Dr. Mohamadi grew up in the Cleveland Park area of Washington and attended the Sidwell Friends School before completing his undergraduate studies at Yale University in 1998. He returned to DC and attended the George Washington University School of Medicine, where he graduated in 2002.
Following medical school, Dr. Mohamadi received his training in Pediatrics at the Mount Sinai School of Medicine in New York City, where he was selected as chief resident for his final year. He then completed his subspecialty fellowship in Pediatric Endocrinology at the Johns Hopkins School of Medicine in Baltimore, MD before returning the to the DC area to open his practice.
Dr. Mohamadi has received numerous honors and awards during his career. In 2007, he was awarded a Lawson Wilkins Pediatric Endocrine Society Research Fellowship Award for his studies on the genetics of growth hormone deficiency. Related to this research, he also was selected as a finalist for the Johns Hopkins Department of Medicine Clinical Research Award in 2007 and was the winner of an Endocrine Society Research Poster Award in 2008. More recently, Dr. Mohamadi was selected as one of “America’s Top Physicians” by the Consumer Research Council of America in 2009 and as a member of Madison’s “Who’s Who” the same year.
Dr. Mohamadi treats children under the age of 18 with the entire spectrum of endocrine conditions. His areas of expertise and interests include weight management; disorders of growth, development, and puberty; hyperlipidemia (including elevated cholesterol); and abnormalities of bone, thyroid, adrenal glands, and hormones in children.